Ignite Creation Date:
2024-05-06 @ 12:05 AM
Last Modification Date:
2024-10-26 @ 10:44 AM
Study NCT ID:
NCT01482715
Status:
COMPLETED
Last Update Posted:
2023-06-09
First Post:
2011-11-22
Brief Title:
A Study of Oral Rucaparib in Patients With a Solid Tumor Phase I or With gBRCA Mutation Ovarian Cancer Phase II
Sponsor:
pharmaand GmbH
Organization:
pharmaand GmbH
Organization Data
Organization:
pharmaand GmbH
Class:
INDUSTRY
Study ID:
CO-338-010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
pharmaand GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Foundation Medicine | INDUSTRY |